A phase I/II trial of bryostatin 1 administered intravenously in patients with Alzheimer's disease.
Phase of Trial: Phase I/II
Latest Information Update: 26 Jan 2012
At a glance
- Drugs Bryostatin-1 (Primary)
- Indications Alzheimer's disease; Cognition disorders; Dementia
- Focus Therapeutic Use
- 26 Jan 2012 New trial record